BPC-157 / TB-500

Batch #: BPCTB-20-601

Verified Potency: 11.47mg / 12.66mg

$225.00

A synergistic research blend pairing BPC-157 and full-length Thymosin Beta-4 to investigate combined effects on tissue repair, vascular development, and cellular recovery pathways.

Size

3rd-Party Janoshik Verification

Ships by Calculating...

Disclaimer

For Research Use Only. Not for human consumption or therapeutic treatment.

About BPC-157 / TB-500

This precision-formulated blend combines BPC-157, a gastric-derived peptide renowned for its influence on blood vessel formation and tissue homeostasis, with full-length Thymosin Beta-4 (TB4), a 43-amino-acid protein that plays a critical role in cellular movement, actin regulation, and structural organization. Together, they create a powerful research tool for investigating how peptides work synergistically to support natural recovery processes, modulate inflammatory responses, and optimize tissue remodeling. Scientists utilize this combination to explore the intersection of gastrointestinal-derived repair signaling and cytoskeletal dynamics, particularly in models examining accelerated healing, structural integrity, and multi-pathway regenerative mechanisms.

Product Specifications

BPC-157 (10mg) and Thymosin Beta-4 (10mg) Lyophilized Powder in 3ml vial

Application

Cellular repair, angiogenesis, and tissue remodeling research

Appearance

Solid, white powder in 3mL glass ampule

Chemical Formula

BPC-157: C62H98N16O22 TB4: C212H350N56O78S

CAS number

BPC-157: 137525-51-0 TB4: 77591-33-4

Molecular Weight

BPC-157: ~1419.5 g/mol TB4: ~4963.4 g/mol

FAQs

What is the BPC-157 and TB-500 blend?

This blend combines two peptides studied in tissue repair research. BPC-157 is a 15-amino acid peptide derived from a segment of human gastric juice protein. TB-500 is a synthetic fragment of Thymosin Beta-4, the principal G-actin sequestering protein in mammalian cells. The blend is formulated as a single lyophilized powder in a sealed 3mL glass ampule for combined research applications.

Why are BPC-157 and TB-500 studied together?

BPC-157 and TB-500 are studied together because they act through complementary mechanisms in tissue repair models. BPC-157 research focuses on nitric oxide system modulation, vascular endothelial growth factor upregulation, and gastrointestinal cytoprotection. TB-500 research focuses on actin polymerization, endothelial cell migration, and anti-inflammatory signaling. Combined administration is studied in models where multiple repair pathways are relevant.

What tissues has BPC-157 been studied in?

BPC-157 has been studied in animal models involving tendon, muscle, ligament, bone, skin, and gastrointestinal tissues. Research in the Journal of Orthopaedic Research reports accelerated healing of transected Achilles tendons in rats. Studies in the Journal of Physiology-Paris describe protection against gastric mucosal damage. Additional research examines BPC-157's effects on surgically created fistulas, transected muscle tissue, and burn wound healing in rodent models.

What tissues has TB-500 been studied in?

TB-500 (Thymosin Beta-4 fragment) has been studied in models involving cardiac tissue, corneal epithelium, skin, and hair follicles. Research in the Proceedings of the National Academy of Sciences reports that Thymosin Beta-4 activates epicardial progenitor cells and promotes coronary vessel formation after myocardial infarction in mice. Corneal wound healing studies show accelerated re-epithelialization following alkali injury in rat models.

Can I buy the BPC-157 and TB-500 blend for research?

Limitless Peptides sells the BPC-157 and TB-500 blend as a lyophilized powder in a sealed 3mL glass ampule. The product is Janoshik verified for identity, potency, and purity. This blend is sold for research use only and is not approved for human consumption. The product page includes the certificate of analysis and a link to the independent Janoshik verification report.

BPC-157 / TB-500

About BPC-157 / TB-500

FAQs

Related Peptides